Drug recall D-0959-2017

Class I Terminated reported Jul 19, 2017

Product

EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21

Reason for recall

Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.

Lots and codes

Lot: HN0063, EXP. 09/2019

Recall details

Recalling firm
Bristol-myers Squibb Company, New Brunswick, NJ
Quantity
48,180 bottles
Distribution
Nationwide in the US
Type
Voluntary: Firm initiated
Recall initiated
June 5, 2017
Terminated
March 15, 2022

Related products